GT200500035A - Macrolidos y metodos para producir los mismos - Google Patents
Macrolidos y metodos para producir los mismosInfo
- Publication number
- GT200500035A GT200500035A GT200500035A GT200500035A GT200500035A GT 200500035 A GT200500035 A GT 200500035A GT 200500035 A GT200500035 A GT 200500035A GT 200500035 A GT200500035 A GT 200500035A GT 200500035 A GT200500035 A GT 200500035A
- Authority
- GT
- Guatemala
- Prior art keywords
- macrolides
- produce
- methods
- same
- neuroregenerating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES NEUROPROTECTORAS Y NEUROREGENERADORAS OBTENIDAS A PARTIR DE CEPAS DE ACTINOMICETOS EN LA QUE SEA DESEABLE ENCONTRAR COMPUESTOS NEUROTROFICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54948004P | 2004-03-02 | 2004-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200500035A true GT200500035A (es) | 2005-10-24 |
Family
ID=34919496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200500035A GT200500035A (es) | 2004-03-02 | 2005-02-25 | Macrolidos y metodos para producir los mismos |
Country Status (21)
Country | Link |
---|---|
US (3) | US7247650B2 (es) |
EP (1) | EP1720886A1 (es) |
JP (2) | JP5032974B2 (es) |
KR (1) | KR20070009578A (es) |
CN (1) | CN1934117A (es) |
AR (1) | AR049681A1 (es) |
AU (1) | AU2005219822A1 (es) |
BR (1) | BRPI0508224A (es) |
CA (1) | CA2556622A1 (es) |
CR (1) | CR8568A (es) |
EC (1) | ECSP066822A (es) |
GT (1) | GT200500035A (es) |
IL (1) | IL177605A0 (es) |
NO (1) | NO20064034L (es) |
PA (1) | PA8624601A1 (es) |
PE (1) | PE20051143A1 (es) |
RU (1) | RU2006129647A (es) |
SG (1) | SG150518A1 (es) |
TW (1) | TW200602347A (es) |
WO (1) | WO2005085257A1 (es) |
ZA (1) | ZA200607347B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2567043A1 (en) * | 2004-06-03 | 2005-12-22 | Wyeth | Biosynthetic gene cluster for the production of a complex polyketide |
WO2006053313A2 (en) * | 2004-11-12 | 2006-05-18 | Wyeth | Elaiophylin biosynthetic gene cluster |
TW200800959A (en) * | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
MX2008011312A (es) * | 2006-03-07 | 2008-09-12 | Wyeth Corp | Analogos de meridamicina para el tratamiento de trastornos neurodegenerativos. |
TW200808741A (en) * | 2006-06-09 | 2008-02-16 | Wyeth Corp | 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts |
TW200811144A (en) * | 2006-06-09 | 2008-03-01 | Wyeth Corp | Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline |
TW200808740A (en) * | 2006-06-09 | 2008-02-16 | Wyeth Corp | Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof |
US7709593B2 (en) | 2006-07-28 | 2010-05-04 | Eastman Chemical Company | Multiple feeds of catalyst metals to a polyester production process |
TW200831096A (en) * | 2006-11-28 | 2008-08-01 | Wyeth Corp | Metabolites of 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof |
CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
EP2077853A1 (en) * | 2007-01-29 | 2009-07-15 | Wyeth | Immunophilin ligands and methods for modulating immunophilin and calcium channel activity |
US20100022766A1 (en) * | 2008-07-25 | 2010-01-28 | Wyeth | Biosynthetic gene cluster for the production of a complex polyketide |
CN102174438B (zh) * | 2011-01-26 | 2012-07-25 | 南京大学 | 新大环内酯及其制备方法和应用 |
CN105456298A (zh) * | 2015-12-01 | 2016-04-06 | 中国人民解放军第二军医大学 | 草苔虫总内酯抗老年痴呆活性及其应用 |
CN110051680B (zh) * | 2018-01-19 | 2022-02-18 | 沈阳福洋医药科技有限公司 | 一种用于预防和/或治疗阿尔茨海默病的药物、组合产品及其应用 |
RU2771046C2 (ru) | 2018-01-19 | 2022-04-25 | Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. | Применение карримицина или его активных ингредиентов |
CN114591286B (zh) * | 2021-04-12 | 2023-05-23 | 南京大学 | 新型大环内酯化合物acautalides A-C及其制备方法和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4975372A (en) | 1989-01-13 | 1990-12-04 | Merck & Co., Inc. | Microbial transformation product of L-683,590 |
EP0528452A1 (en) | 1991-06-19 | 1993-02-24 | Merck & Co. Inc. | Immunomycin enzymatic and/or microbial methylation products |
GB9302016D0 (en) * | 1993-02-02 | 1993-03-17 | Sandoz Ltd | Compounds |
US5798355A (en) * | 1995-06-07 | 1998-08-25 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity |
UA41884C2 (uk) * | 1993-11-05 | 2001-10-15 | Амерікан Хоум Продактс Корпорейшн | Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів |
US5696135A (en) * | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
US6118521A (en) * | 1996-01-02 | 2000-09-12 | Lj Laboratories, L.L.C. | Apparatus and method for measuring optical characteristics of an object |
US6242468B1 (en) | 1997-02-27 | 2001-06-05 | Jia-He Li | Carbamate and urea compositions and neurotrophic uses |
JP3511361B2 (ja) * | 1997-08-04 | 2004-03-29 | セイコーインスツルメンツ株式会社 | 走査プローブ顕微鏡 |
US6111650A (en) * | 1997-08-14 | 2000-08-29 | Rawicz; Andrew | Method and apparatus for color matching of slightly colored translucent objects such as teeth and dental prosthesis, in particular |
EP1720548A1 (en) * | 2004-03-02 | 2006-11-15 | Wyeth | Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents |
AU2005319427B2 (en) * | 2004-12-20 | 2011-11-03 | Wyeth | Rapamycin derivatives and the uses thereof in the treatment of neurological disorders |
HN2005035605A (es) * | 2004-12-20 | 2010-08-05 | Wyeth Corp | Analogos de rapamicina y los usos de los mismos en el tratamiento de trastornos neurologicos, proliferativos e inflamatorios |
-
2005
- 2005-02-25 KR KR1020067017891A patent/KR20070009578A/ko not_active Application Discontinuation
- 2005-02-25 RU RU2006129647/04A patent/RU2006129647A/ru not_active Application Discontinuation
- 2005-02-25 US US11/065,934 patent/US7247650B2/en not_active Expired - Fee Related
- 2005-02-25 CN CNA2005800070291A patent/CN1934117A/zh not_active Withdrawn
- 2005-02-25 JP JP2007501836A patent/JP5032974B2/ja not_active Expired - Fee Related
- 2005-02-25 BR BRPI0508224-2A patent/BRPI0508224A/pt not_active IP Right Cessation
- 2005-02-25 WO PCT/US2005/005895 patent/WO2005085257A1/en active Application Filing
- 2005-02-25 CA CA002556622A patent/CA2556622A1/en not_active Abandoned
- 2005-02-25 EP EP05723668A patent/EP1720886A1/en not_active Withdrawn
- 2005-02-25 SG SG200901025-7A patent/SG150518A1/en unknown
- 2005-02-25 AU AU2005219822A patent/AU2005219822A1/en not_active Withdrawn
- 2005-02-25 GT GT200500035A patent/GT200500035A/es unknown
- 2005-02-28 PA PA20058624601A patent/PA8624601A1/es unknown
- 2005-03-01 AR ARP050100770A patent/AR049681A1/es unknown
- 2005-03-01 TW TW094105998A patent/TW200602347A/zh unknown
- 2005-03-01 PE PE2005000236A patent/PE20051143A1/es not_active Application Discontinuation
-
2006
- 2006-08-21 IL IL177605A patent/IL177605A0/en unknown
- 2006-08-24 CR CR8568A patent/CR8568A/es not_active Application Discontinuation
- 2006-09-01 ZA ZA200607347A patent/ZA200607347B/xx unknown
- 2006-09-04 EC EC2006006822A patent/ECSP066822A/es unknown
- 2006-09-07 NO NO20064034A patent/NO20064034L/no not_active Application Discontinuation
-
2007
- 2007-06-14 US US11/818,535 patent/US20070299019A1/en not_active Abandoned
-
2010
- 2010-12-15 US US12/968,728 patent/US20110144176A1/en not_active Abandoned
-
2012
- 2012-03-14 JP JP2012056599A patent/JP2012153699A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1720886A1 (en) | 2006-11-15 |
CN1934117A (zh) | 2007-03-21 |
ZA200607347B (en) | 2010-02-24 |
US20070299019A1 (en) | 2007-12-27 |
NO20064034L (no) | 2006-11-08 |
TW200602347A (en) | 2006-01-16 |
WO2005085257A1 (en) | 2005-09-15 |
BRPI0508224A (pt) | 2007-07-17 |
JP5032974B2 (ja) | 2012-09-26 |
KR20070009578A (ko) | 2007-01-18 |
ECSP066822A (es) | 2006-11-24 |
PA8624601A1 (es) | 2006-06-02 |
JP2007526307A (ja) | 2007-09-13 |
US20110144176A1 (en) | 2011-06-16 |
SG150518A1 (en) | 2009-03-30 |
CA2556622A1 (en) | 2005-09-15 |
AR049681A1 (es) | 2006-08-30 |
US20050197379A1 (en) | 2005-09-08 |
AU2005219822A1 (en) | 2005-09-15 |
IL177605A0 (en) | 2006-12-10 |
JP2012153699A (ja) | 2012-08-16 |
PE20051143A1 (es) | 2006-02-06 |
US7247650B2 (en) | 2007-07-24 |
RU2006129647A (ru) | 2008-04-10 |
CR8568A (es) | 2007-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200500035A (es) | Macrolidos y metodos para producir los mismos | |
ECSP10010095A (es) | 2'-fluoro-2'-desoxitetrahidrouridinas como inhibidores de citidina desaminasa | |
BRPI0520870B8 (pt) | compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila | |
HN2006037713A (es) | Compuestos utiles en terapia | |
HN2006011218A (es) | Composiciones de tigeciclina y métodos de preparación | |
GT200900027A (es) | Compuestos organicos | |
ITMO20050067A1 (it) | Mezzi di illuminazione e metodo per ottenere mezzi di illuminazione. | |
CR11548A (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
PA8676201A1 (es) | Metodos para sintetizar 3-cianoquinolinas sustituidad y sus intermediarios | |
GT200500269A (es) | Procedimiento | |
BRPI0717460A2 (pt) | Composições de inibidores de chk1 | |
CL2007002519A1 (es) | Compuestos derivados de aminopiridina, inhibidores selectivo sobre aurora a; composicion farmaceutica que comprende a dichos compuestos; combinacion farmaceutica que comprende a dichos compuestos, utiles para inhibir el crecimiento de celulas tumoral | |
DK2041121T3 (da) | Enantioselektiv syntese af pyrrolidinsubstituerede flavoner | |
GT200900259A (es) | Nuevos métodos.- | |
AR058253A1 (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
CR9872A (es) | Diazepinoquinolinas, su sintesis e intermediarios | |
PA8796801A1 (es) | Sintesis quiral de diazepinoquinolinas | |
CL2008001570A1 (es) | Metodo organogenico para transformar celulas o tejidos de soya. | |
GT200600010A (es) | Procedimientos para la preparacion de alcoholes aminoetoxibencilicos | |
DK2046323T3 (da) | Sammensætninger som bidrager til behandling af cancer | |
FI20050970A (fi) | Vähän laajenevat eristävät koostumukset | |
ITMI20061048A1 (it) | Procedimento per la preparazione di magnesio boroidruro cristallino | |
AU307639S (en) | Hole cutter for drilling holes in concrete walls | |
CR10651A (es) | Derivados de feniloxianilina | |
DK2183257T3 (da) | Estere af langkædede alkoholer samt deres fremstilling |